You just read:

Protagonist Therapeutics to Present Preclinical Results on PN-943 at the 15th Congress of European Crohn's and Colitis Organization (ECCO)

News provided by

Protagonist Therapeutics, Inc.

Feb 07, 2020, 07:00 ET